Open AccessSafety of Eptifibatide for Subcortical Stroke Progression
Author(s) -
Sheryl MartinSchild,
Hashem Shaltoni,
Anitha Abraham,
Andrew D. Barreto,
Hen Hallevi,
Nicole R. Gonzales,
James C. Grotta,
Sean I. Savitz
Publication year - 2009
Publication title -
cerebrovascular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 104
eISSN - 1421-9786
pISSN - 1015-9770
DOI - 10.1159/000247604
Subject(s) - eptifibatide , medicine , stroke (engine) , discontinuation , anesthesia , cardiology , myocardial infarction , percutaneous coronary intervention , mechanical engineering , engineering
There is no proven treatment for stroke progression in patients with subcortical infarcts. Eptifibatide, a glycoprotein IIb/IIIa inhibitor, might halt stroke progression by improving flow in the microcirculation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom